LCN2 and metabolic dysfunction-associated steatotic liver disease: found that Lcn-2 may disrupt the integrity and function of the BBB by changing the expression of tight junction proteins Claudin5, ZO-1 and increasing the expression of pro-inflammatory cytokines IL-6 and IL-β in brain endothelial cells in NAFLD mouse model (55).